Bladder cancer is a prevalent malignancy with millions of sufferers worldwide. The high recurrence rate following treatment requires an active surveillance regime for people with a history of bladder cancer.
Clinical management and monitoring of bladder cancer after surgery is traditionally performed by urine analysis, cytology and cystoscopy. However, cystoscopy is an invasive and unpleasant procedure, and new tumours may not necessarily occur at the same location. As a result, new non-invasive but highly sensitive tests are required.
Further details: Precision medicine for bladder cancer